Advertisement

Topics

Uncertainties in Assessing Stroke Risk in Atrial Fibrillation

06:57 EDT 20 Mar 2017 | AHC Media

An analysis of 34 randomized trials in atrial fibrillation patients not on anti-coagulation showed considerable variation in stroke rates corresponding to their predicted risk by the CHA2DS2-VASc scores. When these scores are 2 or less, stroke rates are low enough to question the benefit versus risk of anti-coagulation therapy.

Original Article: Uncertainties in Assessing Stroke Risk in Atrial Fibrillation

NEXT ARTICLE

More From BioPortfolio on "Uncertainties in Assessing Stroke Risk in Atrial Fibrillation"

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...